| Name | Title | Contact Details |
|---|
3PSC is a Cape Canaveral, FL-based company in the Business Services sector.
Silverfort is a leading company in identity security, based in Tel Aviv, Israel, and founded in 2016. It provides a unified platform that enhances identity protection across various environments, including cloud, on-premises, and industrial settings. The company focuses on simplifying identity security by integrating seamlessly with existing infrastructure, addressing security gaps that can arise from fragmented solutions. The key offerings from Silverfort include a Unified Identity Protection Platform that secures sensitive resources, Runtime Access Protection (RAP) technology for inline security controls, and Adaptive Multi-Factor Authentication (MFA) for risk-based authentication. Additionally, Silverfort employs an AI-driven risk assessment engine to evaluate account risks and provides continuous monitoring and alerting to detect unusual activities. This comprehensive approach helps organizations maintain robust identity security while ensuring compliance with cybersecurity standards.
Urban Institute is one of the leading providers in Business Services. It is based in Washington, DC. To find more information about Urban Institute, please visit www.urban.org.
CEPI – Coalition for Epidemic Preaparedness Innovations - is a new broad international coalition set up to fund development of vaccines against emerging infectious diseases with epidemic potential, where there are few market incentives. The epidemics like Ebola and SARS we have seen over the past years, have demonstrated the need for vaccines. Development of a vaccine takes many years, and it is too late to start when the outbreak has started. By having vaccines on the shelf ready for phase III early in an outbreak, we can demonstrate the vaccine efficacy and stop the outbreak while it is small. CEPI has already launched two calls for proposals; one for development of vaccines against MERS, Lassa and Nipah and one for the development of rapid response vaccine technology to enable development of vaccines against new and unknown diseases. CEPI was launched in January 2017 and now has funding totalling $620 million from soverign investors and philantropic institutions. CEPI`s investors are: The Governments of Australia, Belgium, Canada, Japan and Norway, as well as the Wellcome Trust and the Bill&Melinda Gates Foundation. In addition the European Commission will co fund activities with €250 million.
Mediguard (Canada) Inc is a Brampton, ON-based company in the Business Services sector.